cysteamine has been researched along with Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; Li, W; Ling, S; Liu, X; Luo, Y; Wang, A; Xu, B; Yao, X; Zhang, S; Zhou, Y; Zong, W | 1 |
| Cho, SW; Choi, SY; Eum, WS; Han, KH; Hwang, HS; Kang, TC; Kim, DS; Kim, DW; Kim, SM; Kim, YN; Kwon, HY; Lim, SS; Park, J; Sohn, EJ | 1 |
2 other study(ies) available for cysteamine and Dermatitis
| Article | Year |
|---|---|
Transglutaminase 3 Attenuates Skin Inflammation in Psoriasis by Inhibiting NF-κB Activation through Phosphorylated STAT3-TET3 Signaling.
Topics: Animals; Cysteamine; Cytokines; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Keratinocytes; Mice; Mice, Inbred BALB C; NF-kappa B; Psoriasis; RNA, Small Interfering; Skin; STAT3 Transcription Factor; Transglutaminases | 2022 |
Effects of pergolide mesylate on transduction efficiency of PEP-1-catalase protein.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Cell Line; Cysteamine; Dermatitis; Drug Delivery Systems; Humans; Keratinocytes; Male; Mice; Mice, Inbred ICR; Peptides; Pergolide; Protein Transport; Recombinant Fusion Proteins; Tetradecanoylphorbol Acetate | 2011 |